Funding for this research was provided by:
Turku University Hospital (13856)
Academy of Finland (258814)
Turku University Foundation (NA)
the Finnish MS Foundation (NA)
Jane ja Aatos Erkon Säätiö
Text and Data Mining valid from 2018-05-01
Received: 4 August 2017
Accepted: 9 April 2018
First Online: 1 May 2018
: Sirpa Jalkanen is the founder of VAP-1.
: All study protocols and procedures were reviewed and approved by the national Animal Experiment Board of Finland and the Regional State Administrative Agency for Southern Finland (license number ESAVI/3046/04.10.07/2014) and conducted in accordance with the relevant European Union directive.
: Sirpa Jalkanen is a shareholder in Faron Ventures Ltd. Other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.